Fundraising FoxImmunaratx
Amsterdam, NL · 1 known investors
Find your way into Immunaratx
Sign up to see every warm intro you have to Immunaratx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Immunaratx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Immunara is developing a precision immunotherapy that uses patented single domain antibody (SdAb) carriers to deliver antigens or immunomodulators selectively to antigen-presenting cells, training the immune system to target specific threats. Spun out from Amsterdam UMC, the company is building a platform for targeted and personalized immunotherapy aimed at cancer and other immune-mediated diseases.
Founders & leadership
JD
Joke den HaanScientific Co-founder
Investors · 1
Frequently asked questions
- What does Immunaratx do?
- Immunara is developing a precision immunotherapy that uses patented single domain antibody (SdAb) carriers to deliver antigens or immunomodulators selectively to antigen-presenting cells, training the immune system to target specific threats. Spun out from Amsterdam UMC, the company is building a platform for targeted and personalized immunotherapy aimed at cancer and other immune-mediated diseases.
- Who are Immunaratx's investors?
- Immunaratx's investors include Mana Ventures.
- Where is Immunaratx headquartered?
- Immunaratx is headquartered in Amsterdam, NL.